| NCT05891548 | Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration | COMPLETED | PHASE2 | 2023-05-31 | 2024-08-20 | 2024-08-20 |
| NCT04626128 | Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD | COMPLETED | PHASE1, PHASE2 | 2020-12-15 | 2022-10-13 | 2022-10-13 |
| NCT03203447 | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVO | TERMINATED | PHASE3 | 2018-03-05 | 2018-12-18 | 2018-12-18 |
| NCT03126786 | Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema | COMPLETED | PHASE2 | 2017-07-11 | 2018-04-17 | 2018-04-17 |
| NCT03097315 | Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis | COMPLETED | PHASE3 | 2017-04-04 | 2018-01-24 | 2018-01-24 |
| NCT02980874 | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO | TERMINATED | PHASE3 | 2017-01-31 | 2018-12-10 | 2018-12-10 |
| NCT02949024 | Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema | COMPLETED | PHASE1, PHASE2 | 2016-11-10 | 2017-10-17 | 2017-10-17 |
| NCT02595398 | Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis | COMPLETED | PHASE3 | 2015-11-17 | 2018-01-18 | 2018-01-18 |
| NCT02303184 | Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO | COMPLETED | PHASE2 | 2015-01 | 2016-03 | 2016-03 |
| NCT02255032 | Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis | COMPLETED | PHASE2 | 2014-10 | 2016-01 | 2015-12 |
| NCT01789320 | Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis | COMPLETED | PHASE1, PHASE2 | 2013-02 | 2015-03 | 2015-03 |